Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mediator removal with CRRT: complement and cytokines

W Silvester1

  • 1Department of Intensive Care Medicine, Austin and Repatriation Medical Centre, Melbourne, Australia. bills@austin.unimelb.edu.au

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|December 31, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating survival in advanced cancer: a comparison of estimates made by oncologists and patients.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2019
Same author

Attitudes and self-reported end-of-life care of Australian and New Zealand intensive care doctors in the context of organ donation after circulatory death.

Anaesthesia and intensive care·2018
Same author

Organ donation after circulatory death in a university teaching hospital.

Anaesthesia and intensive care·2016
Same author

Prevalence and predictors of advance directives in Australia.

Internal medicine journal·2014
Same author

A checklist for streamlining organ donation after cardiac death.

Anaesthesia and intensive care·2011
Same author

Continuous hemofiltration for anasarca: recovery of renal function after 71 liters of net ultrafiltration.

The International journal of artificial organs·2008

Continuous renal replacement therapy (CRRT) may offer nonrenal benefits in septic shock by reducing inflammatory mediators. However, the clinical significance of these effects requires further investigation.

Area of Science:

  • Critical Care Medicine
  • Nephrology
  • Immunology

Background:

  • Animal sepsis models suggest hemofiltration may improve hemodynamic changes in septic shock.
  • Continuous renal replacement therapy (CRRT) is being investigated for potential nonrenal benefits in septic patients.

Purpose of the Study:

  • To review the evidence on the mechanisms and effectiveness of CRRT in removing inflammatory mediators in sepsis.
  • To elucidate the role of extracorporeal removal of cytokines and complement factors in sepsis and multiple organ failure.

Main Methods:

  • Review of in vitro, animal, and human studies.
  • Analysis of various mediators (e.g., TNF-alpha, IL-6, complement factors) and blood purification methods (diffusion, convection, adsorption).
  • Evaluation of different membrane types (polyacrylonitrile, polysulfone, polyamide).

Related Experiment Videos

Main Results:

  • Plasma levels of some inflammatory mediators appear to be reduced by CRRT, utilizing membrane adsorption and convection.
  • The clinical significance of these mediator reductions remains uncertain.

Conclusions:

  • CRRT shows potential for reducing inflammatory mediators in sepsis.
  • Further research is needed to fully understand the role and clinical impact of CRRT in treating septic patients.